Evidence map›Paper›PMID 34155274›Full record

ArticleScientific reports2021

Comprehensive analysis of bacteriocins in Streptococcus mutans.

Atsuko Watanabe, Miki Kawada-Matsuo, Mi Nguyen-Tra Le, Junzo Hisatsune, Yuichi Oogai, Yoshio Nakano, Masanobu Nakata, Shouichi Miyawaki, Motoyuki Sugai, Hitoshi Komatsuzawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Raman signatures ofFrontiers in microbiology · 2026
    Article
  3. Raman signatures ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Raman signatures ofFrontiers in microbiology · 2026
    Article
  6. Article
  7. The MutRS quorum-sensing system controls lantibiotic mutacin production in the human pathogenProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. The two-component regulatory systems GraRS and SrrAB mediateApplied and environmental microbiology · 2024
    Article
  10. Ursoricin, a bacteriocin ofApplied and environmental microbiology · 2024
    Article
  11. Probiotic Effect ofPathogens (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Isolation ofiScience · 2023
    Article
  17. Selective Bacteriocins: A Promising Treatment forAntibiotics (Basel, Switzerland) · 2023
    Article
  18. Role of Metabolic Adaptation ofPathogens (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Atsuko WatanabeDepartment of Orthodontics and Dentofacial Orthopedics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Miki Kawada-MatsuoDepartment of Bacteriology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3, Hiroshima City, Hiroshima, 734-8551, Japan.
Mi Nguyen-Tra LeDepartment of Bacteriology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3, Hiroshima City, Hiroshima, 734-8551, Japan.
Junzo HisatsuneProject Research Centre for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan.
Yuichi OogaiDepartment of Oral Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yoshio NakanoDepartment of Chemistry, Nihon University School of Dentistry, Tokyo, Japan.
Masanobu NakataDepartment of Oral Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Shouichi MiyawakiDepartment of Orthodontics and Dentofacial Orthopedics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Motoyuki SugaiProject Research Centre for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan.
Hitoshi KomatsuzawaDepartment of Bacteriology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3, Hiroshima City, Hiroshima, 734-8551, Japan. komatsuz@hiroshima-u.ac.jp.
Hiroshima University · JPKagoshima University · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus mutans produces bacteriocins that show antibacterial activity against several bacteria. However, comprehensive analysis of these bacteriocins has not been well done. In this study, we isolated 125 S. mutans strains from volunteers and determined their whole genome sequence. Based on the genome analysis, the distribution of each bacteriocin gene (mutacins I-IV, K8 and Smb) was investigated. We found 17, 5, and 2 strains showing 100% matches with mutacin I, mutacin II and mutacin III, respectively. Five mutacin III-positive strains had 2 mismatches compared to mature mutacin III. In 67 mutacin IV-positive strains, 38 strains showed 100% match with mutacin IV, while 29 strains showed some variations. In 23 mutacin K8- and 32 mutacin Smb-positive strains, all except one mutacin K8-positive strain showed 100% match with the mature peptides. Among 125 strains, 84 (65.1%), 26 (20.2%), and 5 (3.9%) strains were positive for one, two and three bacteriocin genes, respectively. Then, the antibacterial activity against oral streptococci and other oral bacterial species was investigated by using bacteriocin gene single-positive strains. Each bacteriocin gene-positive strain showed a different pattern of antibacterial activity. These results speculate that individual S. mutans strains may affect the bacterial composition of dental plaques.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsAntibiosisBacteriocinsGene Expression Regulation, BacterialHumansMicrobial Sensitivity TestsMutationPromoter Regions, GeneticRegulatory Sequences, Nucleic AcidStreptococcus mutansAnti-Bacterial AgentsBacteriocins

Identifiers

PMID34155274
PMCPMC8217173
OpenAlexW3175856315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.